Related Experiment Video
Updated: Jun 26, 2026

An In Vitro Model of a Parallel-Plate Perfusion System to Study Bacterial Adherence to Graft Tissues
Published on: January 7, 2019
The endocarditis team: a review
Aoife Maher1,2,3, Larry M Baddour4, Sami El Dalati5
1Department of Cardiology, Mater Private Hospital, Dublin, Ireland.
Insights
Establishing an endocarditis team (ET) significantly reduces mortality and improves diagnosis for infective endocarditis (IE) patients. This multidisciplinary approach enhances patient outcomes in complex IE cases.
Area of Science:
- Cardiology
- Infectious Diseases
- Healthcare Management
Background:
- Infective endocarditis (IE) presents diagnostic and management challenges, leading to high morbidity and mortality.
- The 2015 European Society of Cardiology (ESC) guidelines recommend establishing an endocarditis team (ET) for IE management.
- Evidence supporting the efficacy of ETs in improving patient care is crucial.
Purpose of the Study:
- To evaluate the evidence supporting the implementation of endocarditis teams (ETs) in managing infective endocarditis (IE).
- To assess the impact of ETs on patient outcomes and quality of care for IE.
Main Methods:
- A systematic review of nineteen before-and-after observational studies was conducted.
- The studies included a total of 5,327 patients (3,069 before ET, 2,258 after ET).
- No randomized controlled trials (RCTs) were identified.
Main Results:
- Implementation of ETs was associated with a significant reduction in in-hospital mortality (20.9% to 16.3%).
- The proportion of IE cases with unidentified organisms decreased significantly after ET introduction (23.8% to 9.8%).
- Consistent observational evidence supports the effectiveness of ETs.
Conclusions:
- Endocarditis teams (ETs) are effective in reducing mortality and improving diagnostic accuracy in infective endocarditis (IE) patients.
- Despite limitations in study design, the consistent findings support widespread ET implementation.
- Multidisciplinary models like ETs are biologically plausible and align with successful approaches in other complex diseases.
Introduction:
Infective endocarditis (IE) is a complex infection of the endocardium, associated with significant morbidity and mortality. Diagnosing IE can be challenging, as shown by the evolution of original diagnostic criteria. Managing IE is difficult, involving decisions about diagnosis, antibiotic therapy, and surgery. Given these challenges, the 2015 European Society of Cardiology (ESC) IE Guidelines recommended establishing an endocarditis team (ET) in centers managing IE. This review evaluates the evidence supporting ETs.
Areas Covered:
We identified 19 before-and-after studies including 5,327 patients (3,069 before and 2,258 after ET introduction) that examined the impact of implementing an ET on the quality of care for patients with IE. No RCTs were found. The studies were reviewed and revealed a significant reduction in in-hospital mortality (20.9-16.3% [RR 0.71, CI 0.54 to 0.93], p = 0.0154)) and the proportion of endocarditis cases in which an organism was not identified (23.8-9.8%; [RR 0.50, 0.39 to 0.64, p < 0.0001]) following ET introduction.
Expert Opinion:
This review provides consistent observational evidence that ETs are effective in saving lives. Despite limitations, the consistency of effect across multiple studies, biological plausibility, and alignment with successful multidisciplinary models in other diseases support the widespread implementation of ETs.
Related Concept Videos
Endocarditis I: Introduction
Endocarditis III: Medical Management
Endocarditis IV: Nursing Management
Endocarditis II: Clinical Features of Infective Endocarditis
Myocarditis III: Medical Management
Pericarditis III: Medical Management
